- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Canadian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
18
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
18 companies
1CM
Market Cap: CA$45.9m
Operates as a multi-jurisdictional cannabis company in Canada.
EPIC
CA$0.24
7D
-38.5%
1Y
-4.0%
Covalon Technologies
Market Cap: CA$59.8m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.15
7D
-1.8%
1Y
-35.8%
Auxly Cannabis Group
Market Cap: CA$195.5m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.15
7D
11.1%
1Y
328.6%
Cronos Group
Market Cap: CA$1.4b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$3.73
7D
5.4%
1Y
32.3%
Medicenna Therapeutics
Market Cap: CA$85.1m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.96
7D
-5.0%
1Y
-47.8%
MediPharm Labs
Market Cap: CA$29.5m
Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
LABS
CA$0.07
7D
0%
1Y
0%
Medicure
Market Cap: CA$11.5m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.10
7D
0%
1Y
8.9%
Delivra Health Brands
Market Cap: CA$5.9m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.20
7D
7.9%
1Y
2.5%
Steep Hill
Market Cap: CA$970.7k
Does not have significant operations.
STPH
CA$0.06
7D
0%
1Y
140.0%
RAMM Pharma
Market Cap: CA$1.8m
Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.015
7D
50.0%
1Y
n/a
Crescita Therapeutics
Market Cap: CA$9.0m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.47
7D
4.4%
1Y
-22.1%
PharmaTher Holdings
Market Cap: CA$32.8m
A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
PHRM
CA$0.37
7D
-3.9%
1Y
48.0%
Avant Brands
Market Cap: CA$9.0m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.84
7D
3.7%
1Y
-23.6%
Captor Capital
Market Cap: CA$1.8m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.47
7D
0%
1Y
n/a
Vaxil Bio
Market Cap: CA$520.5k
A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.
VXL
CA$0.20
7D
-4.9%
1Y
n/a
Sona Nanotech
Market Cap: CA$68.9m
Operates as a nanotechnology life sciences company.
SONA
CA$0.60
7D
1.7%
1Y
114.3%
Microbix Biosystems
Market Cap: CA$37.0m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.28
7D
16.7%
1Y
-16.4%
C21 Investments
Market Cap: CA$55.9m
An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.
CXXI
CA$0.52
7D
10.6%
1Y
73.3%